Meihua International Medical Technologies Co., Ltd. (MHUAF): Gross Profit

Annual figures by period end, from SEC filings.

$19.16M
Year ended 2025-12-31
-20.5%
3-year compound annual growth
-12.4%
5-year compound annual growth
$39.81M2019-12-31: $32.21M2020-12-31: $37.16M2021-12-31: $39.81M2022-12-31: $38.10M2023-12-31: $33.20M2024-12-31: $33.30M2025-12-31: $19.16M$19.16M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$19.16M-42.5%2026-04-29, From 2025-01-01
2024-12-31$33.30M+0.3%2026-04-29, From 2024-01-01
2023-12-31$33.20M-12.9%2026-04-29, From 2023-01-01
2022-12-31$38.10M-4.3%2025-04-25, From 2022-01-01
2021-12-31$39.81M+7.1%2024-04-24, From 2021-01-01
2020-12-31$37.16M+15.4%2023-08-29, From 2020-01-01
2019-12-31$32.21Mn/a2022-07-29, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$19.16M-42.5%
LENSAR, Inc. (LNSR)2025-12-31$27.12M+4.9%
CVRx, Inc. (CVRX)2025-12-31$48.34M+12.5%
AVITA Medical, Inc. (RCEL)2025-12-31$58.82M+6.6%
Apyx Medical Corp (APYX)2025-12-31$33.04M+12.5%
Carlsmed, Inc. (CARL)2025-12-31$38.04M+89.7%
Sight Sciences, Inc. (SGHT)2025-12-31$66.67M-2.4%
PRO DEX Inc (PDEX)2026-06-30$24.34M+24.7%
TELA Bio, Inc. (TELA)2025-12-31$54.34M+16.9%

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗